Perindopril erbumine and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Perindopril erbumine (perindopril erbumine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Pain.

The phase IV clinical study analyzes which people have Nosebleed when taking Perindopril erbumine. It is created by eHealthMe based on reports of 8,308 people who have side effects when taking Perindopril erbumine from the FDA, and is updated regularly.

What is Perindopril erbumine?

Perindopril erbumine has active ingredients of perindopril erbumine. It is often used in high blood pressure. eHealthMe is studying from 8,958 Perindopril erbumine users. Check the latest studies of Perindopril erbumine.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,080 drugs and 3,093 conditions by eHealthMe. Check the latest studies of Nosebleed.

On Jul, 28, 2026

8,308 people reported to have side effects when taking Perindopril erbumine.
Among them, 52 people (0.63%) have Nosebleed.

Could Perindopril erbumine cause Nosebleed?

Among these 52 people:

How long have people been on Perindopril erbumine when they have Nosebleed? *

What is the gender of people who have Nosebleed when taking Perindopril erbumine? *

female: 32.61 %
male: 67.39 %

What is the age of people who have Nosebleed when taking Perindopril erbumine? *

What are other drugs people take besides Perindopril erbumine? *

What are other side effects people have besides Nosebleed? *

Headache (pain in head): 22 people, 42.31%
Dizziness: 17 people, 32.69%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 12 people, 23.08%
Hyperhidrosis (abnormally increased sweating): 11 people, 21.15%
Abdominal Pain Upper: 11 people, 21.15%
Visual Impairment: 11 people, 21.15%
Vasodilatation (widening of blood vessels resulting from relaxation of smooth muscle cells within the vessel walls): 10 people, 19.23%
Chest Pain: 10 people, 19.23%
Anaemia (lack of blood): 10 people, 19.23%
Joint Pain: 10 people, 19.23%

What are the existing conditions these people have? *

Pain: 11 people, 21.15%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 17.31%
Constipation: 9 people, 17.31%
Thyroid Diseases: 9 people, 17.31%
Osteoporosis (bones weak and more likely to break): 9 people, 17.31%
Gastric Disorder (disease of stomach): 9 people, 17.31%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 13.46%
Hypoglycemia (low blood sugar): 7 people, 13.46%
Nephropathy (damage to or disease of a kidney): 5 people, 9.62%
Hypokalemia (low potassium): 3 people, 5.77%

* Approximation only. Some reports may have incomplete information.

Do you take Perindopril erbumine and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Perindopril erbumine:

Perindopril erbumine (8,958 reports)

Nosebleed treatments and more:

Nosebleed (92,075 reports)

Browse all side effects of Perindopril erbumine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Nosebleed (2,080 drugs)

Browse all the conditions that are associated with Nosebleed:

Nosebleed (3,093 conditions)

Related publications that referenced our studies

Krishnan K, Krishnasamy K, "Evaluation of anaphylactic reaction as an adverse event for perindopril erbumine tablets", International Current Pharmaceutical Journal, 2014 Mar .
Krishnan K, Krishnasamy K, "Evaluation of anaphylactic reaction as an adverse event for perindopril erbumine tablets", International Current Pharmaceutical Journal, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on perindopril erbumine (the active ingredients of Perindopril erbumine) and Perindopril erbumine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.